Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07217990
PHASE1/PHASE2

Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer

Sponsor: Ohio State University Comprehensive Cancer Center

View on ClinicalTrials.gov

Summary

This study will evaluate the efficacy and non-inferiority of a non-surgical approach for the treatment of patients with locally advanced breast cancer.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

84

Start Date

2026-04-15

Completion Date

2027-12-31

Last Updated

2026-02-17

Healthy Volunteers

No

Interventions

DRUG

Neoadjuvant Chemotherapy

Participants will receive standard of care neoadjuvant chemotherapy

RADIATION

Radiation Therapy

Radiotherapy simulation parameters will be at the discretion of the treating physician to account for the patient's body habitus, tumor bed location, and tolerability of the prone or supine positions, however, the recommended approach will be whole-breast RT (WBRT) in the prone position, for cT1-3 N0 patients who achieve ecCR. For cT1-2 N1 patients who achieve ecCR WBRT with nodal inclusion and lymph node boost will be performed in the supine position.

PROCEDURE

MRI

Participants will undergo MRI

PROCEDURE

Breast Cancer Surgery

Participants will undergo surgery to treat their breast cancer. Either a lumpectomy or a mastectomy will be performed.

PROCEDURE

Biopsy

Participants undergo biopsy

PROCEDURE

Biospecimen collection

Participants undergo blood and plasma collection

Locations (1)

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, United States